These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9437410)

  • 1. No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure.
    Yue QY; Beermann B; Lindström B; Nyquist O
    J Intern Med; 1997 Dec; 242(6):491-5. PubMed ID: 9437410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide.
    Härdig L; Daae C; Dellborg M; Kontny F; Bohmer T
    J Intern Med; 2000 May; 247(5):597-600. PubMed ID: 10809999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study.
    Seligmann H; Halkin H; Rauchfleisch S; Kaufmann N; Motro M; Vered Z; Ezra D
    Am J Med; 1991 Aug; 91(2):151-5. PubMed ID: 1867241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
    Zenuk C; Healey J; Donnelly J; Vaillancourt R; Almalki Y; Smith S
    Can J Clin Pharmacol; 2003; 10(4):184-8. PubMed ID: 14712323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J; Díez J;
    Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
    Noe LL; Vreeland MG; Pezzella SM; Trotter JP
    Clin Ther; 1999 May; 21(5):854-66. PubMed ID: 10397380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy.
    Shimon I; Almog S; Vered Z; Seligmann H; Shefi M; Peleg E; Rosenthal T; Motro M; Halkin H; Ezra D
    Am J Med; 1995 May; 98(5):485-90. PubMed ID: 7733128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
    Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
    Müller K; Gamba G; Jaquet F; Hess B
    Eur J Heart Fail; 2003 Dec; 5(6):793-801. PubMed ID: 14675858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
    Dormans TP; Gerlag PG
    Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review.
    Katta N; Balla S; Alpert MA
    Am J Med; 2016 Jul; 129(7):753.e7-753.e11. PubMed ID: 26899752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of thiamine deficiency in a stable heart failure outpatient cohort on standard loop diuretic therapy.
    Teigen LM; Twernbold DD; Miller WL
    Clin Nutr; 2016 Dec; 35(6):1323-1327. PubMed ID: 26923517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
    Fukui M; Tsujino T; Hirotani S; Ito H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Kawabata M; Masuyama T
    Heart Vessels; 2017 Jul; 32(7):865-871. PubMed ID: 28105515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
    Masuyama T; Tsujino T; Origasa H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Ito H
    Circ J; 2012; 76(4):833-42. PubMed ID: 22451450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of spironolactone therapy on thiamine blood levels in patients with heart failure.
    Rocha RM; Silva GV; de Albuquerque DC; Tura BR; Albanesi Filho FM
    Arq Bras Cardiol; 2008 May; 90(5):324-8. PubMed ID: 18516403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.